ACY-1215 for Relapsed/Refractory Lymphoid Malignancies
NCT02091063
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
23
Enrollment
OTHER
Sponsor class
Stopped
Lack of funding
Conditions
Lymphoma
Lymphoid Malignancies
Interventions
DRUG:
ACY-1215
Sponsor
Jennifer Amengual
Collaborators
[object Object]